Craneware plc (AIM:CRW)
London · Delayed Price · Currency is GBP · Price in GBX 1,264.00
-20.00 (-1.56%)
Aug 17, 2026, 4:08 PM GMT
Craneware Market Cap
Craneware has a market cap or net worth of 434.98 million as of August 17, 2026. Its market cap has decreased by -45.52% in one year.
Market Cap
434.98M
Enterprise Value
424.54M
Revenue
157.02M
Ranking
n/a
PE Ratio
27.52
Stock Price
1,264.00
ChartMarket Cap Chart
Since September 13, 2007, Craneware's market cap has increased from 27.00M to 434.98M, an increase of 1,511.32%. That is a compound annual growth rate of 15.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 434.98M | -35.74% |
| Dec 31, 2025 | 676.88M | -8.39% |
| Dec 31, 2024 | 738.88M | 20.69% |
| Dec 29, 2023 | 612.23M | -3.93% |
| Dec 30, 2022 | 637.29M | -26.03% |
| Dec 31, 2021 | 861.52M | 41.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.75B |
| GSK plc | 72.83B |
| Haleon | 31.32B |
| Smith & Nephew | 9.22B |
| Advanced Medical Solutions Group | 609.20M |
| Oxford Biomedica | 589.46M |
| Allergy Therapeutics | 332.46M |
| Avacta Group | 299.78M |